Institutional investors control 11.78% of the outstanding shares in GSK. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended June 2014, these large investors purchased a net $14.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NFJ INVESTMENT GROUP LLC Bought 6.0 Million shares of GlaxoSmithKline PLC
HOTCHKIS & WILEY CAPITAL MANAGEM... Bought 4.9 Million shares of GlaxoSmithKline PLC
MANAGED ACCOUNT ADVISORS LLC Bought 2.1 Million shares of GlaxoSmithKline PLC